Skip to content
AnalystLens

AMPHENOL CORP /DE/ 8-K Report, Bylaw Amendment (May 16, 2025)

Reports
Shareholder Matters·Corporate Changes·Exhibits & Filings
Filing Date
Filed May 16, 2025
Period End
May 15, 2025
Security
APH
In the record · 2016–202610-K1110-Q328-K138

APH filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 138 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Apr ’17Apr ’17
  2. Material agreement8-K · May ’20May ’20
  3. Leadership change8-K · Jan ’23Jan ’23
  4. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 8-K filed May 16, 2025. Cited figures are marked; the original filing is the authoritative source.

Amphenol Corporation (APH) filed an 8-K on May 16, 2025, reporting on key outcomes from its annual stockholders' meeting held on May 15, 2025.

The most significant development for investors is the approval of an amendment to the company's Restated Certificate of Incorporation. This amendment dramatically increases the number of authorized Class A Common Stock shares by 3 billion, from 2 billion to a total of 5 billion. This move provides Amphenol with substantial flexibility for future capital raising, potential acquisitions, stock-based compensation plans, or other corporate initiatives that may require a larger authorized share base.

Key Highlights

  1. Stockholders approved a significant increase in authorized common stock, raising the total from 2 billion to 5 billion shares.
  2. The amendment to the Restated Certificate of Incorporation provides Amphenol with substantial future flexibility for capital allocation and growth strategies.
  3. All incumbent director nominees were overwhelmingly elected to the board.
  4. The selection of Deloitte & Touche LLP as the independent public accountants was ratified by stockholders.
  5. An advisory vote to approve the compensation of named executive officers passed.
  6. A stockholder proposal regarding support for special shareholder meeting improvement was not approved.
  7. The Charter Amendment became effective upon filing with the Secretary of State of Delaware on May 15, 2025.

Frequently Asked Questions

  1. What is the primary financial implication of the increase in authorized shares?

    The increase in authorized shares provides Amphenol with greater financial flexibility. It allows the company to issue more stock in the future for various purposes, such as funding acquisitions, raising capital through stock offerings, implementing employee stock purchase plans, or facilitating stock-based compensation, without needing immediate shareholder approval for each issuance.

  2. Why did Amphenol need to increase its authorized shares so significantly?

    While the filing doesn't provide specific reasons, a substantial increase like this often anticipates future growth opportunities, strategic acquisitions, or the need for more flexible capital structures. It ensures the company has the necessary shares available to act swiftly on opportunities without potential delays from seeking further shareholder approval.

  3. What was the voting outcome on the increase of authorized shares?

    The Charter Amendment to increase the authorized shares of Common Stock was approved by stockholders. However, it's worth noting that while a majority voted 'FOR' (856,330,104 shares), there was also a significant number of 'AGAINST' votes (244,620,802 shares).

  4. Were there any other significant proposals voted on at the meeting?

    Yes, stockholders re-elected all director nominees, ratified the appointment of Deloitte & Touche LLP as independent accountants, and approved the advisory vote on executive compensation. A stockholder proposal on special shareholder meeting improvement was not approved.